title: [Effect of tumor necrosis factor alpha on the efficiency of anti-rabies vaccination].
abstract: Recombinant tumor necrosis factor-alpha (TNF-alpha) improved the survival of random-bred albino mice vaccinated with antirabies vaccine after infection with rabies CVS strain. The agent dose of 0.1 microgram/animal, injected 1 day postvaccination, was the most effective. Improvement of antiviral resistance of non-vaccinated mice under the effect of TNF-alpha suggests that the effect of this factor on nonspecific resistance factors is one of the probable mechanisms of its modulating effect.
authors.forename: A M
authors.initials: AM
authors.lastname: Shestopalov
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Rassadkin
authors.forename: E N
authors.initials: EN
authors.lastname: Ustinova
authors.forename: E D
authors.initials: ED
authors.lastname: Danilenko
authors.forename: A O
authors.initials: AO
authors.lastname: Belkina
authors.forename: N M
authors.initials: NM
authors.lastname: Pustoshilova
authors.forename: V I
authors.initials: VI
authors.lastname: Masycheva
mesh_terms: D000818:Animals; D004347:Drug Interactions; D008297:Male; D051379:Mice; D011818:Rabies / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*; D014611:Vaccination
chemical_list: D011819:Rabies Vaccines; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha